請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64608完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳明賢(Ming-Shiang Wu),王秀伯(Hsiu-Po Wang) | |
| dc.contributor.author | Yu-Jen Fang | en |
| dc.contributor.author | 方佑仁 | zh_TW |
| dc.date.accessioned | 2021-06-16T17:57:46Z | - |
| dc.date.available | 2012-09-19 | |
| dc.date.copyright | 2012-09-19 | |
| dc.date.issued | 2012 | |
| dc.date.submitted | 2012-08-12 | |
| dc.identifier.citation | 1. Abid S, Siddiqui S, Jafri W. Discriminant value of Rome III questionnaire in dyspeptic patients.Saudi J Gastroenterol. 2011 Mar-Apr;17(2):129-33.
2. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20(5):347-55. 3. Ang TL, Fock KM, Teo EK, Chan YH, Ng TM, Chua TS, Tan JY. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. J Gastroenterol. 2006 Jul;41(7):647-53. 4. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl. 1996;215:38-47. 5. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul;137(1):94-100. 6. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, Kato T. Gastric leptin and Helicobacter pylori infection. Gut. 2001 Sep;49(3):324-9. 7. Bazzoli F, Palli D, Zagari RM, Festi D, Pozzato P, Nicolini G, Masala G, Fossi S, Ricciardiello L, Panuccio D, Roda E. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors. Aliment Pharmacol Ther. 2001 Jul;15(7):1001-7. 8. Bazzoli F, De Luca L, Pozzato P, Zagari RM, Fossi S, Ricciardiello L, Nicolini G, Berretti D, Roda E. Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data. Gut. 2002 May; 50 Suppl 4:iv33-5. 9. Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996 Jun; 38(6):822-5. 10. Bisschops R, Karamanolis G, Arts J, Caenepeel P, Verbeke K, Janssens J, Tack J. Relationship between symptoms and ingestion of a meal in functional dyspepsia.Gut. 2008 Nov;57(11):1495-503. 11. Bjarnason T, Sigurdardottir TJ. Psychological distress during unemployment and beyond: social support and material deprivation among youth in six northern European countries. Soc Sci Med. 2003 Mar;56(5):973-85. 12. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun;3(6):543-52. 13. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia Clin Gastroenterol Hepatol. 2004 Nov; 2(11):985-96. 14. Chen TS, Luo JC, Chang FY. Psychosocial-spiritual factors in patients with functional dyspepsia: a comparative study with normal individuals having the same endoscopic features. Eur J Gastroenterol Hepatol. 2010 Jan; 22(1):75-80. 15. Davis M. The role of the amygdala in fear and anxiety.Annu Rev Neurosci 1992; 15: 353–75. 16. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep; 38(9):1569-80. 17. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003 Aug 15; 18(4):387-93. 18. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54. 19. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol. 2001 Feb; 96(2):303-14. 20. Feinle-Bisset C, Horowitz M. Dietary factors in functional dyspepsia. Neurogastroenterol Motil. 2006 Aug; 18(8):608-18. 21. Fischler B, Tack J, De Gucht V, Shkedy ZI, Persoons P, Broekaert D, Molenberghs G, Janssens J. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology. 2003 Apr; 124(4):903-10. 22. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am J Gastroenterol. 2012 Jun; 107(6):912-21. 23. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. 24. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci. 1996 Apr; 41(4):689-96. 25. Ghoshal UC, Singh R, Chang FY, Hou X, Wong BC, Kachintorn U; Functional Dyspepsia Consensus Team of the Asian Neurogastroenterology and Motility Association and the Asian Pacific Association of Gastroenterology. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil. 2011 Jul; 17(3):235-44. 26. Gonlachanvit S. Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil. 2010 Apr; 16(2):131-8. 27. Gschossmann JM, Haag S, Holtmann G. Epidemiological trends of functional gastrointestinal disorders. Dig Dis. 2001; 19(3):189-94. 28. Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009 Apr; 21(4):417-24. 29. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8. 30. Hu WH, Lam KF, Wong YH, Lam CL, HUIi WM, Lai KC, Wong BC, Lam SK. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol. 2002 May; 17(5):545-51. 31. Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, Xia HX, Lam SK, Wong BC. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002 Dec; 16(12):2081-8. 32. Hui WM, Shiu LP, Lam SK. The perception of life events and daily stress in nonulcer dyspepsia. Am J Gastroenterol. 1991 Mar; 86(3):292-6. 33. Hsu YC, Liou JM, Liao SC, Yang TH, Wu HT, Hsu WL, Lin HJ, Wang HP, Wu MS. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria. Am J Gastroenterol. 2009 Oct; 104(10):2534-42. 34. Jeong JJ, Choi MG, Cho YS, Lee SG, Oh JH, Park JM, Cho YK, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol. 2008 Nov 7;14(41):6388-94. 35. Jin X, Li YM. Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter. 2007 Oct;12(5):541-6. 36. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia. Trop Gastroenterol. 2001 Oct-Dec; 22(4):194-6. 37. Johannesson E, Simren M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.Am J Gastroenterol. 2011 May;106(5):915-22. 38. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006 Feb;130(2):296-303. 39. Kawashima J, Ohno S, Sakurada T, Takabayashi H, Kudo M, Ro S, Kato S, Yakabi K. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol. 2009 Aug 22;44(10):1046-54. 40. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9. 41. Konturek SJ, Brzozowski T, Konturek PC, Schubert ML, Pawlik WW, Padol S, Bayner J. Brain-gut and appetite regulating hormones in the control of gastric secretion and mucosal protection. J Physiol Pharmacol. 2008 Aug;59 Suppl 2:7-31. 42. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, Leelakusolvong S, Luo JY, Manan C, Park HJ, Piyaniran W, Qureshi A, Long T, Xu GM, Xu L, Yuen H. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol. 2003 Jul;18(7):796-802. 43. Lacy BE, Everhart K, Crowell MD. Functional dyspepsia is associated with sleep disorders. Clin Gastroenterol Hepatol. 2011 May;9(5):410-4.. 44. Laheij RJ, De Koning RW, Horrevorts AM, et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol 2004; 38:490-5. 45. Lankarani KB, Moghadami M, Masoumpoor M, Geramizadeh B, Omrani GR. Serum leptin level in patients with functional dyspepsia. Dig Liver Dis. 2004 Nov; 36(11):717-21. 46. Lanzini A, Magni P, Petroni ML, Motta M, Lanzarotto F, Villanacci V, Amato M, Mora A, Bertolazzi S, Benini F, Ricci C. Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):907-13. 47. Lee KJ, Cha DY, Cheon SJ, Yeo M, Cho SW. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion. 2009 Jun 3; 80(1):58-63. 48. Lee MB, Liao SC, Lee YJ, Wu CH, Tseng MC, Gau SF, Rau CL.Development and verification of validity and reliability of a short screening instrument to identify psychiatric morbidity.J Formos Med Assoc. 2003 Oct; 102(10):687-94. 49. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig. Dis. Sci. 1991 Sep; 36(5):1249–54. 50. Li Y, Nie Y, Sha W, Su H. The link between psychosocial factors and functional dyspepsia: an epidemiological study. Chin Med J (Engl). 2002 Jul; 115(7):1082-4. 51. Lin W, Eaker EY, Sarosiek I, McCallum RW. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol. 1999 Sep; 94(9):2384-9. 52. Locke GR 3rd, Weaver AL, Melton LJ 3rd, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004 Feb;99(2):350-7. 53. Lu CL, Chen CY, Chang FY, Kang LJ, Lee SD, Wu HC, Kuo TS. Impaired postprandial gastric myoelectrical activity in Chinese patients with nonulcer dyspepsia. Dig Dis Sci. 2001 Feb; 46(2):242-9. 54. Lu CL, Wu YT, Yeh TC, Chen LF, Chang FY, Lee SD, Ho LT, Hsieh JC. Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil. 2004 Oct; 16(5):575-87. 55. Lu CL, Lang HC, Chang FY, Chen CY, Luo JC, Wang SS, Lee SD. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol. 2005 Apr; 40(4):402-11. 56. Lu IC, Yen Jean MC, Lei SM, Cheng HH, Wang JD. BSRS-5 (5-item Brief Symptom Rating Scale) scores affect every aspect of quality of life measured by WHOQOL-BREF in healthy workers. Qual Life Res. 2011 Nov; 20(9):1469-75. 57. Mahadeva S, Yadav H, Rampal S, Goh KL. Risk factors associated with dyspepsia in a rural Asian population and its impact on quality of life. Am J Gastroenterol. 2010 Apr;105(4):904-12. 58. Mahadeva S, Yadav H, Rampal S, Everett SM, Goh KL. Ethnic variation, epidemiological factors and quality of life impairment associated with dyspepsia in urban Malaysia. Aliment Pharmacol Ther. 2010 May;31(10):1141-51. 59. Manabe N, Haruma K. Diagnosis and treatment of dyspeptic patients in Japan. J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:27-31. 60. Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, Milbradt TC, Von Reisswitz PS, Berwanger O,Bressel M, Edelweiss MI, Marini SS, Molina CG, Folador L, Lunkes RP, Heck R, Birkhan OA, Spindler BM, Katz N, Colombo Bda S, Guerrieri PP, Renck LB, Grando E, Hocevar de Moura B, Dahmer FD, Rauber J, Prolla JC. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med. 2011 Nov 28;171(21):1929-36. 61. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut. 1998 Jun;42(6):814-22. 62. Miwa H, Ghoshal UC, Gonlachanvit S, Gwee KA, Ang TL, Chang FY, Fock KM, Hongo M, Hou X, Kachintorn U, Ke M, Lai KH, Lee KJ, Lu CL, Mahadeva S, Miura S, Park H, Rhee PL, Sugano K, Vilaichone RK, Wong BC, Bak YT. Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil. 2012 Apr; 18(2):150-68. 63. Miwa H. Life style in persons with functional gastrointestinal disorders--large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil. 2012 May; 24(5):464-71. 64. Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, Axon A. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol. 2000 Jun; 95(6):1448-55. 65. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ. 2000 Sep 16; 321(7262):659-64. 66. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr 19 ;( 2):CD002096. 67. Mones J, Adan A, Segu JL, Lopez JS, Artes M, Guerrero T. Quality of life in functional dyspepsia. Dig Dis Sci. 2002 Jan; 47(1):20-6. 68. Nakajima S, Takahashi K, Sato J, Fukuda M, Yamamoto K, Inoue T, Okumura Y, Fujiyama Y. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.J Gastroenterol Hepatol. 2010 May; 25 Suppl 1:S138-43. 69. Nishizawa T, Suzuki H, Nomoto Y et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment. Pharmacol.Ther. 2006 July; 2(1): 104–10. 70. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab. 2005 Jan; 90(1):10-6. 71. Park H. Functional gastrointestinal disorders and overlap syndrome in Korea. J Gastroenterol Hepatol. 2011 Apr; 26 Suppl 3:12-4. 72. Parkman HP, Miller MA, Trate D, Knight LC, Urbain JL, Maurer AH, Fisher RS. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol. 1997 Jun; 24(4):214-9. 73. Pajala M, Heikkinen M, Hintikka J. Mental distress in patients with functional or organic dyspepsia: a comparative study with a sample of the general population. Aliment Pharmacol Ther. 2005 Feb 1; 21(3):277-81. 74. Pereira-Lima JG, Scholl J, Pinheiro JB, Pereira-Lima L, Riemann JF. Helicobacter pylori-associated gastritis: does it play a role in functional dyspepsia? Z Gastroenterol. 1995 Aug;33(8):421-5. 75. Rhee PL, Kim YH, Son HJ, Kim JJ, Koh KC, Paik SW, Rhee JC, Choi KW. Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol. 1999 Nov;94(11):3165-9. 76. Saito Y, Suzuki H, Tsugawa H, Suzuki S, Matsuzaki J, Hirata K, Hibi T. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology. 2011 Jan; 140(1):189-98. 77. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003 Apr; 98(4):783-8. 78. Sanger GJ, Lee K. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Nat Rev Drug Discov. 2008 Mar; 7(3):241-54. 79. Sayette MA. Does drinking reduce stress?Alcohol Res Health. 1999;23(4):250-5. 80. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001 May-Jun;20(3):103-6. 81. Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov;99(11):2210-6. 82. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996 Apr; 110(4):1036-42. 83. Sugano K. Should we still subcategorize helicobacter pylori -associated dyspepsia asfunctional disease? J Neurogastroenterol Motil. 2011 Oct; 17(4):366-71. 84. Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil. 2011 Apr; 17(2):124-30. 85. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004 Oct; 127(4):1239-55. 86. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001 Sep; 121(3):526-35. 87. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998 Dec; 115(6):1346-52. 88. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79. 89. Talley NJ, Phillips SF, Melton J, 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111(8):671-4. 90. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999 Sep; 45 Suppl 2:II37-42. 91. Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. Am J Gastroenterol. 1999 Oct;94(10):2845-54. 92. Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal distribution of food during gastric emptying in functional dyspepsia patients. Gut. 1994 Mar; 35(3):327-32. 93. Tucci A, Corinaldesi R, Stanghellini V, Tosetti C, Di Febo G, Paparo GF, Varoli O, Paganelli GM, Labate AM, Masci C, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology. 1992 Sep; 103(3):768-74. 94. Turkkan E, Uslan I, Acarturk G, Topak N, Kahraman A, Dilek FH, Akcan Y, Karaman O, Colbay M, Yuksel S. Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? J Gastroenterol. 2009; 44(1):66-70. 95. Vandenbergh J, Dupont P, Fischler B, Bormans G, Persoons P, Janssens J, Tack J.Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology. 2005 Mar; 128(3):564-73. 96. Vandenberghe J, Vos R, Persoons P, Demyttenaere K, Janssens J, Tack J. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut. 2005 Jul; 54(7):914-9. 97. Vandenberghe J, Dupont P, Van Oudenhove L, Bormans G, Demyttenaere K, Fischler B, Geeraerts B, Janssens J, Tack J. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology. 2007 May;132(5):1684-93 98. Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Fischler B, Demyttenaere K, Tack J. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut. 2008 Dec;57(12):1666-73 99. Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, Bormans G, Vanderghinste D, Van Laere K, Demyttenaere K, Fischler B, Tack J. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H (2) (15) O-PET study. Am J Gastroenterol. 2010 Apr; 105(4):913-24. 100. Vilaichone RK, Mahacahai V, Tumwasorn S, Kachintorn U. CagA genotype and metronidazole resistant strain of Helicobacter pylori in functional dyspepsia in Thailand. J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:46-8. 101. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007 May;132(6):2116-30. 102. Wretmark G, Astrom J, Eriksson M. The Maudsley Personality Inventory as a prognostic instrument. Br J Psychiatry. 1970 Jan; 116(530):21-6. 103. Wyeth JW. Functional gastrointestinal disorders in New Zealand. J Gastroenterol Hepatol. 2011 Apr; 26 Suppl 3:15-8. 104. Xiao YL, Peng S, Tao J, Wang AJ, Lin JK, Hu PJ, Chen MH. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am J Gastroenterol. 2010 Dec; 105(12):2626-31. 105. Zagari RM, Law GR, Fuccio L, Cennamo V, Gilthorpe MS, Forman D, Bazzoli F. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010 Apr; 138(4):1302-11. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64608 | - |
| dc.description.abstract | 研究背景:
功能性消化不良(functional dyspepsia)是一個異質性很高的症狀型疾病 (heterogeneous symptom disease)。診斷依據為源自於上腸胃道(胃,十二指腸)的慢性或反覆性症狀,且常規檢查不能有可解釋症狀的器質病灶(organic lesions)及代謝性疾病(metabolic disease)。其盛行率很高,是臨床上常見的問題,雖無致命危險,但常造成患者生活品質不良。此類患者的高就醫率,也增加了整個社會在健康照護上的支出。許多致病機轉,包括腸胃道運動功能不良、內臟神經高敏感度、胃幽門桿菌、精神病理壓力、生活方式等都曾被報告與功能性消化不良的致病機轉有關,這可能是由於功能性消化不良是一高度異質性的疾病。於是新的診療準則(羅馬III準則,Rome III criteria) 提議以更專一的疾病診斷來取代功能性消化不良;同時作上腹痛症候群(epigastric pain syndrome)和餐後不適症候群(postprandial distress syndrome)的次分類。以往的研究發現教育程度、生活方式、精神病理壓力等危險因子和功能性消化不良有關,但未有一致的結果,且這些危險因子在不同次分類有無不同並不清楚。此外,臺灣本土的相關研究也不多。 研究目的: 探討功能性消化不良病人的危險因子並比較這些危險因子在不同次分類之間有無不同。 研究方法: 自2011年1月至2012年05月,我們以羅馬III準則來評估所有因上腹部症狀而到臺大醫院及雲林分院腸胃科門診的病人,收案病患必須填寫病史、腸胃科症狀問卷、生活習慣、簡式健康表、羅馬III準則的標準診斷問卷,以確認症狀符合功能性消化不良的定義,而且必須接受上消化道內視鏡檢查,併胃鏡切片,以確認無引起症狀的器質病灶。另於同時間,搜集所有來兩院區健檢中心接受健康檢查,無任何消化不良相關症狀的健康對照組,對照組也須填寫包括病史、症狀問卷等,排除重大疾病,並皆接受上消化道內視鏡檢查,排除器質病灶;且皆有接受C-13碳吹氣試驗,確認胃幽門桿菌的感染情形。我們先以多元線性回歸分析方法比較對照組、消化不良與功能性消化不良在各因子包括生活方式、胃幽門桿菌的感染情形等是否有獨立相關性。再以相同方法比較對照組、功能性消化不良不同次分類在各因子之間是否有獨立相關性。最後比較功能性消化不良的次分類之間各因子之間是否有獨立相關性。 研究結果: 對照組有1311位符合收案標準,但檢查後有46位癌症、86位糖尿病、2位慢性腎臟病變、3位肝硬化、58位逆流性食道炎、85位潰瘍遭到排除,總共1031位無症狀的對照組。兩院區計有共2378位主訴消化不良相關症狀病人,排除80位癌症、79位腹部開刀、256位糖尿病病史、38位肝硬化、13位慢性腎臟病變、14位問卷填寫不全、80位不願參與研究、116位曾接受胃幽門桿菌根除治療,而剩下的1702位中有818位符合羅馬III準則對功能性消化不良的診斷標準。經內視鏡檢查,306位有病灶(243位潰瘍、60位胃食道逆流)予以排除。最後共有512位功能性消化不良 (69.9%為女性,平均50歲);其中310位(60.5%)可診斷為上腹痛症候群,而368位(71.9%)可診斷為餐後不適症候群,17位(3.3%)無法歸類,因此有176位病人(34.4%)在次分類診斷上是重疊的(同時符合上腹痛症候群和餐後不適症候群)。經多元線性回歸分析,發現功能性消化不良在下列因子都呈現獨立正相關:女性(勝算比1,82;95%信賴區間1.19~2.78)、嚼檳榔(勝算比5.04;95%信賴區間為1.92~13.20)、服用止痛藥習慣(勝算比7.52;95%信賴區間4.34~13.03)、重度睡眠障礙(勝算比2.64;95%信賴區間1.46~4.76)、緊張不安感【輕度(勝算比2.57;95%信賴區間1.69~3.94);中度(勝算比4.09;95%信賴區間2.23~7.51);重度(勝算比5.27;95%信賴區間1.95~14.30)】、憂鬱感【輕度(勝算比1.93;95%信賴區間1.24~3.00);中度(勝算比2.42;95%信賴區間1.12~5.22);重度(勝算比5.29;95%信賴區間1.59~17.66)】、幽門螺旋桿菌感染(勝算比1.60;95%信賴區間1.14~2.24)、合併非靡爛性食道炎(勝算比12.10;95%信賴區間7.92~18.49)、腸躁症(勝算比8.26;95%信賴區間4.78~14.30)。另外,年齡(勝算比0.95;95%信賴區間0.93~0.97)、大專以上學歷(勝算比0.42;95%信賴區間0.24~0.72)呈現負相關。其他各因子包括職業、婚姻、BMI、抽煙習慣等較無顯著相關。比較不同次分類診斷的病人與健康對照組發現餐後不適症候群診斷的患者下列因子呈現獨立正相關,但上腹痛症候群沒有相關性:喝酒(勝算比1.74;95%信賴區間為1.04~2.89)、睡眠障礙【輕度(勝算比2.24;95%信賴區間1.37~3.66);中度(勝算比2.17;95%信賴區間1.23~3.82);重度(勝算比5.89;95%信賴區間3.07~11.31)】、憂鬱感【輕度(勝算比1.86;95%信賴區間1.11~3.13);中度(勝算比3.15;95%信賴區間1.29~7.68);重度(勝算比8.25;95%信賴區間2.13~31.91)】、幽門螺旋桿菌感染(勝算比1.59;95%信賴區間1.08~2.35)。比較不同次分類診斷之間病人,發現符合餐後不適症後群與睡眠障礙呈現獨立正相關【輕度(勝算比2.05;95%信賴區間1.10~3.79);中度(勝算比6.43;95%信賴區間2.83~14.58);重度(勝算比8.20;95%信賴區間3.37~19.89)】。其他因子在次分類之間等較無顯著相關。 結論: 依據羅馬III準則對功能性消化不良的定義與分類,功能性消化不良有較高的吃止痛藥習慣、睡眠障礙、緊張不安感、憂鬱感覺、幽門螺旋桿菌感染、較多合併非靡爛性食道炎、腸躁症。而符合餐後不適症後群和喝酒、睡眠障礙、憂鬱感、胃幽門螺旋桿菌感染有獨立相關性。 | zh_TW |
| dc.description.abstract | Background:
Functional dyspepsia (FD) is a heterogeneous symptom disease. The diagnosis of FD is based on chronic or recurrent symptoms thought to originate in gastroduodenal region without organic lesions or metabolic disease, on routine diagnostic examinations. FD is a common disorder with significant impact on quality of life and health care burden. Numerous pathophysiological mechanisms, such as gastroduodenal motor dysfunction, visceral hypersensitivity, Helicobacter pylori (H. pylori) infection, psychosocial factors, diet, and life style have been suggested to play a role in the development of FD. Because of its heterogeneity, new Rome III criteria are implemented for diagnosis and further subgroup classification of FD, consisting of epigastric pain syndrome (EPS) and postprandial distress syndrome (PDS). Although previous studies have revealed several risk factors such as life style, H. pylori, and psychopathological factors were associated with FD, the results were still controversial. Moreover, studies based on new Rome III criteria and addressing risk factors in different subgroups are few. We also noted that studies from Taiwan are scanty. Aims: We aimed to investigate risk factors of FD in Taiwan based on the Rome III criteria and compare different risk factors in two subgroups of FD. Methods: From January 2011 to May 2012, consecutive dyspeptic outpatients were assessed with standard Rome III diagnostic questionnaire in National Taiwan University Hospital and its Yuan-Lin Branch. All patients received detailed history taking, including demographic data, lifestyle and 5-item Brief Symptom Rating Scale (BSRS-5). Then they underwent upper gastrointestinal endoscopy and laboratory checkup to exclude organic disease or other metabolic disorder. Radom biopsy was obtained from antrum and body for pathology, Helicobacter pylori (H. pylori) culture, and rapid urea test. To select control, we enrolled all consecutive asymptomatic subjects participating in self-paid health checkup from Health Examination Center. Similar work up was performed for control group except that they received additional 13-UBT. Multiple linear regression models were used for statically analyses. Results: There were 1311 health subjects enrolled for screening as control. After exclusion of 46 subjects with cancer history, 86 diabetes mellitus, 2 chronic kidney disease, 3 liver cirrhosis, 58 reflux esophagitis and 85 peptic ulcers, a total of 1031 subjects were selected as control. There were 2378 symptomatic patients from outpatient department. Among them, 80 patients with cancer, 79 with history of abdominal operation, 74 diabetes mellitus, 38 liver cirrhosis, 13 chronic kidney diseases, 14 incomplete questionnaires, 80 refusal, and 116 with history of H. pylori eradication were excluded. Before investigation, 818 patients fulfilled Rome III criteria for FD. After eaxinations, 306 patients with organic lesions (243 peptic ulcers, 60 reflux esophagitis) were excluded. Finally, 512 patients (69.9% female mean age 50 years old) were subjected for analyses. There was an overlap (n=176, 34.4%) between the patients diagnosed with EPS (n=310, 60.5%) and those with PDS (n=368, 71.9%). Seventeen patients did not fit diagnostic criteria of PDS and EPS (3.3%). By multivariable linear regression analysis, the following factors were associated with increasing risk of FD:female gender (odd ratio(OR):1,82, 95% confidence interval(CI)1.19~2.78)、bet nut chewing(OR:5.04, 95% CI1.92~13.20)、NASID (OR:7.52, 95% CI 4.34~13.03)、severe sleep disturbance(OR:2.64, 95% CI1.46~4.76)、anxiety【mild(OR:2.57, 95% CI 1.69~3.94);moderate(OR:4.09, 95% CI 2.23~7.51);serve(OR:5.27, 95%CI 1.95~14.30)】、depression【mild(OR:1.93;95% CI 1.24~3.00);moderate(OR:2.42, 95% CI 1.12~5.22);serve(OR:5.29, 95%CI1.59~17.66)】、H.pylori (OR:1.60, 95% CI 1.14~2.24)、combined non-erosive esophagitis(OR:12.10,95%CI 7.92~18.49)、irritable bowel syndrome(OR:8.26, 95% CI 4.78~14.30). In contrast, age (OR: 0.95, 95%CI0.93~0.97) and education with college level (OR: 0.42, 95% CI0.24~0.72) were associated with decreased risk. The subdivision of FD revealed the following factors were associated with increased risk of PDS but not for EPS:drinking(OR:1.74, 95%CI1.04~2.89)、sleep disturbance mild(OR:2.24, 95%CI1.37~3.66);moderate(OR:2.17, 95%CI1.23~3.82);serve(OR:5.89, 95%CI3.07~11.31)】、depression【mild(OR:1.86, 95%CI1.11~3.13);moderate(OR:3.15, 95%CI1.29~7.68);serve(OR:8.25, 95%CI2.13~31.91)】、H.pylori (OR:1.59, 95%CI1.08~2.35)。Comparison of PDS and EPS demonstrated that the diagnosis of PDS was independently associated with higher proportion of sleep disturbance (p<0.001). Conclusions: Patients fulfilling Rome III FD criteria had more NASID usage, sleep disturbance, anxiety, depression, overlap syndrome with NERD or IBS, and H.pylori infection. Diagnosis of PDS, but not EPS, is independently associated with sleep disturbance. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T17:57:46Z (GMT). No. of bitstreams: 1 ntu-101-P99421007-1.pdf: 884577 bytes, checksum: a31ceb1644b8e6a5b2882e0b51119005 (MD5) Previous issue date: 2012 | en |
| dc.description.tableofcontents | 國立臺灣大學碩士學位口試委員會審定書………….………………………….. i
誌謝 ……………………………………………………………………………..… ii 中文摘要………………………………………………………………………..…… iii 英文摘要(Abstract)…………………………………………………………..…… vi 碩士論文內容 第一章 序論……………………………………………………………………… 1 第一節、功能性消化不良的定義與高度異質性…………………………… 1 第二節、功能性消化不良的臨床重要性…………………………………… 2 第三節、功能性消化不良和胃幽門螺旋桿菌的關係……………………… 3 第四節、功能性消化不良和精神病理的關係……………………………… 5 第五節、功能性消化不良和生活方式的關係……………………………… 6 第六節研究假說與特定目的………………………………………………… 8 第二章 研究方法與材料……………………………………………………..… 9 第一節、研究設計與研究地點及研究對象………………………………… 9 第二節、研究對象的基本紀錄與精神病理量表……………………...……… 10 第三節、羅馬III準則對功能性消化不良的診斷架構及腸躁症、非糜爛性食道炎的定義…………………………………………………...…….…...… 12 第四節、上消化道內視鏡的施行及胃幽門螺旋桿菌感染………………… 13 第五節、統計分析………………………………………………….….…… 14 第三章 研究結果……………………………………………………..……..… 15 第一節、收案病人特徵與消化不良次分類………………………..……… 15 第二節、比較非功能性消化不良、消化不良、功能性消化不良及次分類和各因子的獨立相關性…………………………………………...…….…...… 15 第三節、比較功能性消化不良不同次分類診斷準則和各因子的獨立相關性. 17 第四章 討論……………………………………………………..…………..… 19 第一節、研究的主要發現……..…………………………………………… 19 第二節、功能性消化不良的次分類與重疊狀況…………………….…...… 19 第三節、羅馬III準則功能性消化不良、次分類與胃幽門螺旋桿菌的關聯性-21 第四節、羅馬III準則功能性消化不良、次分類與精神病理、睡眠障礙的關聯性…………………………………………………..……...….…...… 22 第五節、羅馬III準則功能性消化不良、次分類與生活方式的關聯性..… 25 第六節、羅馬III準則功能性消化不良、次分類與重疊綜合症狀的關聯性.. 27 第七節、研究的限制………………………………………………………….. 27 第五章 結論與未來展望………………………………………..…………..… 28 第一節、結論……..……………………………………………..…………… 28 第二節、未來展望…………………….……………………………….....… 28 參考文獻…………………….…………………………………………….....… 30 圖目錄 圖一、功能性消化不良可能的病態生理機制………………………..….....… 48 圖二、內臟神經敏感(visceral hypersensitivity)的病態生理機制……. 49 圖三、功能性消化不良因素分析(factor analysis)研究…………...……... 50 圖四、歐美功能性消化不良的盛行率約5~12%…………………...…...……... 51 圖五、亞洲功能性消化不良的盛行率約為8~23%………………...…...……... 52 圖六、研究受試者收案流程圖………………...……………………......……... 53 圖七、內臟神經敏感的消化不良患者,在較低的胃內撐脹壓力,大腦異常活化的區域………………………………..…...……………………......……... 54 表目錄 表一、羅馬III準則功能性消化不良的次分類:餐後不適症候群與上腹痛症候群……………………………………………………………………….. 55 表二、以多元線性回歸模式檢視比較無消化不良、符合消化不良與符合功能性消化不良病人,在各方面是否有差異……………………….………….. 56 表三、以多元線性回歸模式檢視比較無消化不良、符合餐後不適症候群、與符合功能性上腹痛症候群病人……………………….………………...….. 60 表四、以多元線性回歸模式檢視符合和不符合餐後不適症候群各因子的獨立相關性……………………….…………………………………………...….. 64 表五、以多元線性回歸模式檢視符合和不符合上腹痛症候群各因子的獨立相關性……………………….…………………………………………...….. 68 附錄: 附錄一、基本問卷……………………….………………………………...….. 71 附錄二、羅馬III問題原型………………………………………………...….. 75 附錄三、功能性上消化道疾患評估表…………………………...………...….. 79 附錄四、功能性下消化道疾患評估表…………………………...………...….. 82 | |
| dc.language.iso | zh-TW | |
| dc.subject | 功能性消化不良 | zh_TW |
| dc.subject | 上腹痛症候群 | zh_TW |
| dc.subject | 幽門桿菌 | zh_TW |
| dc.subject | 羅馬III準則 | zh_TW |
| dc.subject | 餐後不適症候群 | zh_TW |
| dc.subject | lifestyle | en |
| dc.subject | Functional dyspepsia | en |
| dc.subject | epigastric pain syndrome | en |
| dc.subject | postprandial distress syndrome | en |
| dc.subject | Rome III criteria | en |
| dc.subject | Helicobacter pylori | en |
| dc.title | 根據羅馬III準則診斷功能性消化不良危險因子研究 | zh_TW |
| dc.title | Risk Factors Study of Functional Dyspepsia Based on Rome III Criteria | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 100-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 盧俊良(Ching-Liang Lu),劉俊人(Chun-Jen Liu) | |
| dc.subject.keyword | 功能性消化不良,上腹痛症候群,餐後不適症候群,羅馬III準則,幽門桿菌, | zh_TW |
| dc.subject.keyword | Functional dyspepsia,epigastric pain syndrome,postprandial distress syndrome,Rome III criteria,Helicobacter pylori,lifestyle, | en |
| dc.relation.page | 83 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2012-08-13 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| 顯示於系所單位: | 臨床醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-101-1.pdf 未授權公開取用 | 863.84 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
